Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1595 studies found for:    "Alzheimer disease familial"
Show Display Options
Rank Status Study
21 Completed Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: PM012;   Drug: Placebo
22 Completed 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
23 Completed Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: GSK239512;   Drug: Placebo
24 Completed Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TC-5619;   Drug: Placebo
25 Recruiting Riluzole in Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Riluzole;   Drug: Placebo
26 Completed Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation
Condition: Alzheimer's Disease
Interventions: Other: Text-based task;   Other: Graphic-based Task
27 Completed
Has Results
Bexarotene Amyloid Treatment for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bexarotene;   Drug: Placebo
28 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
29 Recruiting Trial of Carvedilol in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Carvedilol;   Drug: Placebo
30 Completed Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease
Condition: Alzheimer's Disease
Intervention: Drug: PPI-1019 (APAN)
31 Completed Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-354;   Drug: Placebo
32 Active, not recruiting ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Device: DBS-f on;   Device: DBS-f off
33 Terminated Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Condition: Alzheimer's Disease
Interventions: Drug: ABT-957;   Other: Placebo for ABT-957
34 Recruiting Study to Evaluate Coconut Oil for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Coconut Oil Beverage;   Other: Placebo Beverage
35 Completed Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 1 mg/kg;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 5 mg/kg;   Biological: PF-04360365 10 mg/kg
36 Completed Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
37 Unknown  Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study
Condition: Alzheimer's Disease
Intervention: Drug: F18-AV45
38 Completed Lipitor as a Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Atorvastatin calcium
39 Completed A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 10 mg/kg;   Biological: PF-04360365 7.5 mg/kg;   Drug: placebo
40 Not yet recruiting Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo Capsule(s) Once a Day by Mouth;   Drug: Nilotinib Capsule(s) Once a Day by Mouth

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.